Yamashita, K., Baba, S., Togashi, Y., Dobashi, A., Ae, K., Matsumoto, S., Tanaka, M., Nakamura, T. and Takeuchi, K. Clinicopathologic and genetic characterization of angiofibroma of soft tissue: a study of 12 cases including two cases with AHRR::NCOA3 gene fusion.
Histopathology, in press (2023) |
Isoyama, S., Tamaki, N., Noguchi, Y., Okamura, M., Yoshimatsu, Y., Kondo, T., Suzuki, T., Yaguchi, S. and Dan, S. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors.
Cell Death Dis., 14, 169 (2023) |
Saeki, S., Kumegawa, K., Takahashi, Y., Yang, L., Osako, T., Yasen, M., Otsuji, K., Miyata, K., Yamakawa, K., Suzuka, J., Sakimoto, Y., Ozaki, Y., Takano, T., Sano, T., Noda, T., Ohno, S., Yao, R., Ueno, T. and Maruyama, R. Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
Breast Cancer Res., 25, 21 (2023) |
Akiyoshi, T., Wang, Z., Kaneyasu, T., Gotoh, O., Tanaka, N., Amino, S., Yamamoto, N., Kawachi, H., Mukai, T., Hiyoshi, Y., Nagasaki, T., Yamaguchi, T., Konishi, T., Fukunaga, Y., Noda, T. and Mori, S. Transcriptomic analyses of pretreatment tumor biopsy samples, response to neoadjuvant chemoradiotherapy, and survival in patients with advanced rectal cancer.
JAMA Netw Open, 6, e2252140 (2023) |
Kumegawa, K., Saeki, S., Takahashi, Y., Yang, L., Osako, T., Nakadai, T., Amino, S., Maeda, T., Takahata, C., Mori, S., Noda, T., Ohno, S., Ueno, T. and Maruyama, R. Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.
Br. J. Cancer., in press (2023) |
Misawa, T., Hitomi, K., Miyata, K., Tanaka, Y., Fujii, R., Chiba, M., Loo, T. M., Hanyu, A., Kawasaki, H., Kato, H., Maezawa, Y., Yokote, K., Nakamura, A. J., Ueda, K., Yaegashi, N. and Takahashi, A. Identification of novel senescent markers in small extracellular vesicles.
Int. J. Mol. Sci., in press (2023) |
Haga, Y., Minegishi, Y. and Ueda, K. Frontiers in mass spectrometry-based clinical proteomics for cancer diagnosis and treatment.
Cancer Sci., in press (2023) |
Nakadai, T., Shimada, M., Ito, K., Cevher, M. A., Chu, C. S., Kumegawa, K., Maruyama, R., Malik, S. and Roeder, R. G. Two target gene activation pathways for orphan ERR nuclear receptors.
Cell research, in press (2023) |
Sugawara, S., Okada, R., Loo, T. M., Tanaka, H., Miyata, K., Chiba, M., Kawasaki, H., Katoh, K., Kaji, S., Maezawa, Y., Yokote, K., Nakayama, M., Oshima, M., Nagao, K., Obuse, C., Nagayama, S., Takubo, K., Nakanishi, A., Kanemaki, M. T., Hara, E. and Takahashi, A. RNaseH2A downregulation drives inflammatory gene expression via genomic DNA fragmentation in senescent and cancer cells.
Commun. Biol., 5, 1420 (2022) |
Nakadai, T., Yang, L., Kumegawa, K. and Maruyama, R. Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin opening.
Molecular biology reports, in press (2022) |
